StockData
Hinge Health, Inc. logo

Hinge Health, Inc. (HNGE) stock

HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/30
$114.41−6.88 (-5.67%)

Close on Nov 17, 2026Market cap $9.23BP/E –Yield –

Hinge Health, Inc. grew revenue 49.8% to $720.06M over the twelve months to Jun 30, 2026. Free cash flow was $290.12M, up 218.2% from a year earlier. At the latest close the market valued the company at $9.23B.

Revenue
$720.06M
+49.8% vs. a year earlier
Operating income
$93.67M
TTM Q2 2026
Free cash flow
$290.12M
+218.2% vs. a year earlier
EPS, diluted
-$7.77
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$9.23B
P/E ratio
–
Price to sales
12.82
Price to book
26.81
Dividend yield
–
Free cash flow yield
3.14%

Fundamentals

Revenue
$720.06M
Net income
$109.07M
EPS, diluted
-$7.77
Free cash flow
$290.12M
Book value per share
$4.13
Diluted shares
83M

Trading

Next earnings
Feb 9, 2027 (estimated, after the close)
Previous close
$121.29
Open
$120.90
Day's range
$113.11 – $121.18
Volume
1,744,753
Average volume (20 days)
1,959,556
Index membership
Russell 2000 (since Jun 2026), Russell 3000
52-week range
$30.08 – $126.40
RSI (14 days)
51.6
Volatility (1 year)
51.8%
Relative volume
0.94×

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.

PeriodHNGES&P 500DifferenceHNGE per yearS&P 500 per year
1 month+15.4%-4.0%+19.4 pts
3 months+30.2%-5.0%+35.2 pts
Year to date+146.3%+8.2%+138.1 pts
1 year+180.1%+11.2%+168.9 pts

Four years at a glance

Fiscal years 2022 to 2025 and trailing twelve months, USD

Revenue

$720.06M+49.8% YoY

Gross profit

$608.41M+63.0% YoY

Operating income

$93.67M

Net income

$109.07M

EPS, diluted

–

Free cash flow

$290.12M+218.2% YoY
Reported periodTrailing twelve months

Press releases

Releases Hinge Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Hinge Health

Services-Computer Processing & Data Preparation

Hinge Health operates a digital healthcare technology platform designed to automate and scale care for joint and muscle conditions. The company provides personalized care across the musculoskeletal health continuum, including injury prevention, acute pain management, chronic condition therapy, and pre- and post-surgical rehabilitation. Its platform integrates artificial intelligence-driven motion tracking, a proprietary wearable device for electrical nerve stimulation, and support from a care team of licensed physical therapists, physicians, and health coaches. The company also coordinates in-person care through a high-performance clinical provider network. Its customers primarily include self-insured employers across enterprise and public sectors, fully insured commercial health plans, Medicare Advantage populations, and federal insurance programs.

Company profile, executives and history

Hinge Health stock: common questions

What is Hinge Health's stock price?

HNGE closed at $114.41 on Nov 17, 2026, down 5.67% on the day. Over the past 52 weeks it traded between $30.08 and $126.40.

What is Hinge Health's market cap?

Hinge Health was worth $9.23B at the close on Nov 17, 2026: the share price times the diluted shares outstanding.

What is HNGE's P/E ratio?

Hinge Health lost money over fiscal 2025 (diluted EPS -$7.77), so it has no meaningful P/E ratio.

How much revenue does Hinge Health make?

Hinge Health reported revenue of $720.06M for the twelve months to Jun 30, 2026, up 49.8% from a year earlier.

Does Hinge Health pay a dividend?

No. Hinge Health has not paid a cash dividend over the last twelve months.

When does Hinge Health report earnings next?

Hinge Health is expected to report Q4 FY2026 results on Feb 9, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has HNGE stock performed over the past year?

Including dividends, HNGE returned +180.1% over the past year, against +11.2% for the S&P 500.

How many HNGE shares are sold short?

5M shares were sold short at the latest FINRA report, 12.24% of the float, or 2.4 days of average trading volume.

Who are Hinge Health's competitors?

Companies most similar to Hinge Health by business, industry and size include GDRX, PD, SSTK, INOD, EGHT.

See a number that looks wrong?